GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc. came to market through a business combination with Capstar Special Purpose Acquisition Corp, which traded under the ticker CPSR. Sponsored by Capstar Acquisition Holdings, LLC, the blank-check vehicle completed its initial public offering in 2020 with a focus on the healthcare sector. Gelesis is a commercial-stage biotherapeutics company best known for Plenity, an FDA-cleared superabsorbent hydrogel indicated as an aid for weight management in adults with excess weight or obesity. The Form 8-K filed January 3, 2022 reflects a material corporate event in the company's post-combination lifecycle. Investors and analysts tracking SPAC healthcare dealflow can access complete filing histories, sponsor profiles, and deal timelines on SpacDesk — sign up today for full data access.